Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Y Dirix

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|April 16, 2009
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patientsI Van der Auwera, H J Elst, S J Van Laere, et al.
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
British Journal of Cancer|February 21, 2013
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancerD W Miles, S L de Haas, L Y Dirix, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
British Journal of Cancer|May 4, 2006
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical studyG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies GroupL Y Dirix, F Tonnesen, J Cassidy, et al.
British Journal of Cancer|November 8, 2006
Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
British Journal of Cancer|December 3, 2009
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancerI Van der Auwera, D Peeters, I H Benoy, et al.
The Journal of Pathology|August 4, 2007
Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
British Journal of Cancer|October 28, 2005
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|April 16, 2009
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patientsI Van der Auwera, H J Elst, S J Van Laere, et al.
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
British Journal of Cancer|February 21, 2013
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancerD W Miles, S L de Haas, L Y Dirix, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
British Journal of Cancer|May 4, 2006
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical studyG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies GroupL Y Dirix, F Tonnesen, J Cassidy, et al.
British Journal of Cancer|November 8, 2006
Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
British Journal of Cancer|December 3, 2009
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancerI Van der Auwera, D Peeters, I H Benoy, et al.
The Journal of Pathology|August 4, 2007
Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
British Journal of Cancer|October 28, 2005
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.
Pageof 11